Genomic Valley Biotech Limited (BOM:539206)

Genomic Valley Biotech Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 16, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	77	179	106	66	76	72
Market Cap Growth	-69.61%	68.80%	59.59%	-12.12%	4.87%	172.52%
Enterprise Value	77	175	106	66	76	87
Last Close Price	25.10	58.59	34.71	21.75	24.75	23.60
PE Ratio	-	50.26	698.35	10.25	-	-
PS Ratio	15.54	21.21	64.23	2.44	107.14	34.64
PB Ratio	1.95	4.59	2.99	1.88	2.63	1.61
P/TBV Ratio	1.95	4.59	2.99	1.88	2.63	1.61
P/FCF Ratio	-	1012.58	-	-	-	-
P/OCF Ratio	-	666.52	-	-	-	4.86
EV/Sales Ratio	15.52	20.71	63.98	2.44	107.03	41.60
EV/EBITDA Ratio	136.30	39.77	694.00	7.55	-	-
EV/EBIT Ratio	145.70	40.00	747.67	7.62	-	-
EV/FCF Ratio	-	988.92	-	-	-	-
Debt / Equity Ratio	-	-	-	-	-	0.35
Asset Turnover	-	0.19	0.04	0.66	0.01	0.03
Quick Ratio	-	4.93	3.21	2.53	0.08	0.10
Current Ratio	-	5.73	3.68	2.89	5.31	0.19
Return on Equity (ROE)	-	9.57%	0.43%	20.24%	-0.25%	-11.73%
Return on Assets (ROA)	-	6.29%	0.20%	13.25%	-5.00%	-2.59%
Return on Invested Capital (ROIC)	-0.98%	9.54%	0.40%	27.35%	-10.26%	-5.17%
Return on Capital Employed (ROCE)	-	11.20%	0.40%	24.70%	-12.70%	-4.80%
Earnings Yield	-0.47%	1.99%	0.14%	9.76%	-0.12%	-7.75%
FCF Yield	-	0.10%	-0.19%	-11.72%	-28.17%	-1.31%
Buyback Yield / Dilution	3.56%	-0.24%	0.70%	1.79%	-1.91%	-0.41%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.